Form D · Biotechnology
BlueHealer Inc.
Baltimore, MD · CIK 0002162934
Offering snapshot reported Nov 4, 2026 · SEC filing
- Reported sold
- $1 Offering amount: $1
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 9, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 4, 2026 | Initial | $1 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-603522
Source: Form D, filed Nov 4, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mitchell Lipke | Director |
| Santiago Renteria | Director, Executive |
| Jay Tailor | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3900 N. Charles Street, Apt. #1007
Baltimore, MD, 21218
Baltimore, MD, 21218